Questionnaire on management of nodular thyroid disease (Annual Meeting of the Thyroid Section of the German Society of Endocrinology 2003)

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 3, 2005, Pages 152-159

  Fuhrer D ^a   Mugge C ^a   Paschke, R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

FNAC; Medical treatment; Scintiscan; Thyroid nodule; Ultrasound

Indexed keywords

IODIDE; IODINE; LEVOTHYROXINE;

ASPIRATION CYTOLOGY; CLINICAL PRACTICE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; GERMANY; HUMAN; IODINE DEFICIENCY; MEDICAL EXPERT; MEDICAL SOCIETY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; THYROID CANCER; THYROID NODULE; THYROID SCINTISCANNING; TREATMENT INDICATION;

BIOPSY, NEEDLE; ENDOCRINOLOGY; FOLLOW-UP STUDIES; GERMANY; GOITER, NODULAR; HUMANS; INCIDENCE; IODINE; QUESTIONNAIRES; RADIONUCLIDE IMAGING; SOCIETIES, MEDICAL; THYROID NODULE; THYROXINE;

EID: 17144400377     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837523     Document Type: Conference Paper

References (26)

1. Alexander EK, Hurwitz S, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Larsen PR, Marqusee E. Natural history of benign solid and cystic thyroid nodules. Ann Intern Med 2003; 138: 315-318
2. Bennedbaek FN, Perrild H, Hegedus L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol 2000a; 50: 357-363
3. Bennedbaek FN, Hegedus L. Management of the solitary thyroid nodules results of a North American Survey. J Clin Endocrinol Metab 2000b; 85: 2493-2498
4. Bonnema SJ, Bennedbaek FN, Wiersinga WM. Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol 2000; 53: 5-12
5. Bonnema SJ, Bennedbaek FN, Ladenson PW, Hegedus L. Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 2002; 87: 112-117
6. Brauer VF, Hentschel B, Paschke R. Euthyroid thyroid nodules. Aims, results and perspectives concerning drug therapy. Dtsch Med Wochenschr 2003; 128: 2381-2387
7. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 2002; 87: 4154-4159
8. Dietlein M, Dressler J, Grunwald F, Joseph K, Leisner B, Moser E, Reiners C, Rendl J, Schicha H, Schneider P, Schober O, Deutsche Gesellschaft für Nuklearmedizin. Guideline for in vivo and in vitro procedures for thyroid diseases (version 2). Nuklearmedizin 2003; 42: 109-115
9. Franklyn JA. Commentary: Lack of consensus in Europe in the management of nontoxic multinodular goitre. Clin Endocrinol 2000; 53: 3-4
10. Hampel R, Kulberg T, Klein K, Jerichow JU, Pichmann EG, Clausen V, Schmidt I. Goiter incidence in Germany is greater than previously suspected, ed Klin 1995; 90: 324-329
11. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003; 24: 102-132
12. Kahaly GJ, Dietlein M. Cost estimation of thyroid disorders in Germany. Thyroid 2002; 12: 909-914
13. Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hufner M, Niederle B, Brabant G. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004; 112: 52-58
14. Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T. Risk factors for goiter and thyroid nodules. Thyroid 2002; 12: 879-888
15. Krohn K, Fuhrer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R. Molecular pathogenesis of euthyroid and toxic multinodular goiter. 2004, submitted
16. Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 1992; 93: 359-362
17. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553-559
18. Ortiz R, Hupart KH, DeFesi CR, Surks MI. Effect of early referral to an endocrinologist on efficiency and cost of evaluation and development of treatment plan in patients with thyroid nodules. J Clin Endocrinol Metab 1998; 83: 3803-3807
19. Papini E. The dilemma of non-palpable thyroid nodules. J Endocrinol Invest 2003; 26: 3-4
20. Rojeski MT, Gharib H. Nodular thyroid diesase. evaluation and management. N Engl J Med 1985; 313: 428-436
21. Saller B, Esser H, Horn K et al. Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie. Diagnostik und Therapie von Schilddrüsenkrankheiten. Empfehlungen zur Qualitätssicherung. Der Internist 1997; 38: 177-185
22. Singer A, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med 1996; 156: 2165-2172
23. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-238
24. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126: 226-231
25. Topliss D. Thyroid incidentaloma: the ignorant in pursuit of the inpalpable. Clin Endocrinol (Oxf) 2004; 60: 18-20
26. Volzke H, Ludemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, John U, Meng W. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803-810